BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35524445)

  • 1. Beyond pain control: Outcome and treatment preferences in pediatric migraine.
    Khayata MJ; Farley S; Davis JK; Hornik CP; Reeve BB; Rikhi A; Gelfand AA; Szperka CL; Kessel S; Pezzuto T; Hammett A; Lemmon ME
    Headache; 2022 May; 62(5):588-595. PubMed ID: 35524445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More Than a Headache: Lived Experience of Migraine in Youth.
    Canfora M; Pallotto IK; Davis JK; Farley S; Khayata MJ; Hornik CP; Reeve BB; Rikhi A; Gelfand AA; Szperka CL; Kessel S; Pezzuto T; Hammett A; Lemmon ME
    Pediatr Neurol; 2023 Sep; 146():79-84. PubMed ID: 37451179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes That Matter to Adolescents With Continuous Headache Due to Chronic Migraine and Their Parents: A Pilot Survey Study.
    Morris C; Ross A; Greene K; Irwin S; Wagstaff A; Gelfand A
    Neurology; 2022 Jun; 98(23):e2347-e2355. PubMed ID: 35418460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children.
    Theroux LM; Cappa R; Mendoza A; Mallawaarachchi I; Samanta D; Goodkin HP
    Headache; 2020 Sep; 60(8):1653-1663. PubMed ID: 32853454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for the acute treatment of migraine in children and adolescents.
    Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priority acute and preventive migraine treatment benefits: Results of the Migraine Clinical Outcome Assessment System (MiCOAS) qualitative study of people living with migraine.
    Mangrum R; Gerstein MT; Hall CJ; Buse DC; Houts CR; McGinley JS; McCarrier KP; Lipton RB; Wirth RJ
    Headache; 2023; 63(7):953-964. PubMed ID: 37140142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote electrical neuromodulation for acute treatment of migraine in adolescents.
    Hershey AD; Lin T; Gruper Y; Harris D; Ironi A; Berk T; Szperka CL; Berenson F
    Headache; 2021 Feb; 61(2):310-317. PubMed ID: 33349920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological therapies for the management of chronic and recurrent pain in children and adolescents.
    Fisher E; Law E; Dudeney J; Palermo TM; Stewart G; Eccleston C
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD003968. PubMed ID: 30270423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial.
    Tepper SJ; Grosberg B; Daniel O; Kuruvilla DE; Vainstein G; Deutsch L; Sharon R
    Headache; 2022 Sep; 62(8):989-1001. PubMed ID: 35748757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Analysis of Patient-Reported Outcomes From an Interdisciplinary Pediatric Pain Rehabilitation Program for Children With Chronic Migraine and Headache.
    Benore E; Webster EE; Wang L; Banez G
    Headache; 2018 Nov; 58(10):1556-1567. PubMed ID: 30137650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin for Acute Treatment of Migraine in Children and Adolescents: A Pilot Randomized Trial.
    Gelfand AA; Ross AC; Irwin SL; Greene KA; Qubty WF; Allen IE
    Headache; 2020 Sep; 60(8):1712-1721. PubMed ID: 32965037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA.
    Torres-Ferrus M; Gallardo VJ; Alpuente A; Pozo-Rosich P
    J Headache Pain; 2020 Jul; 21(1):88. PubMed ID: 32652924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
    Cady RK; McAllister PJ; Spierings EL; Messina J; Carothers J; Djupesland PG; Mahmoud RA
    Headache; 2015 Jan; 55(1):88-100. PubMed ID: 25355310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
    Winner PK; McAllister P; Chakhava G; Ailani J; Ettrup A; Krog Josiassen M; Lindsten A; Mehta L; Cady R
    JAMA; 2021 Jun; 325(23):2348-2356. PubMed ID: 34128999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative evidence synthesis of patient perspectives on migraine treatment features and outcomes.
    Urtecho M; Wagner B; Wang Z; VanderPluym JH; Halker Singh RB; Noyes J; Butler ME; Murad MH
    Headache; 2023 Feb; 63(2):185-201. PubMed ID: 36602191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents.
    Fisher E; Law E; Dudeney J; Eccleston C; Palermo TM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011118. PubMed ID: 30939227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.